10-483-310MG

MilliporeSigma™ Calbiochem™ Ack1 Inhibitor, AIM-100

Manufacturer: MilliporeSigma™

CAS Number: 873305-35-2

Select a Size

Pack Size SKU Availability Price
Each of 1 10-483-310MG-Each-of-1 In Stock ₹ 23,852.00

10-483-310MG - Each of 1

₹ 23,852.00

In Stock

Quantity

1

Base Price: ₹ 23,852.00

GST (18%): ₹ 4,293.36

Total Price: ₹ 28,145.36

Color

Yellow

Target Proteins

Ack1

Molecular Formula

C23H21N3O2

Solubility

DMSO

Form

Solid

Description

98% by Chiral HPLC, Enantiomeric excess (ee): 98.29% (based on the ee of (S)-(+)-Tetrahydrofurfurylamine, as determined using Chiral HPLC column)

CAS

873305-35-2

Formula Weight

371.4g/mol

Content And Storage

Avoid Freeze-Thaw Cycles, Protect from Light

Quantity

10 mg

Other Options

Image Product Name Manufacturer Price Range
50-208-1698
Medchemexpress LLC HY-15290 5mg Medchemexpress, AIM-100 CAS:873305-35-2 Purity:>98%
Medchemexpress LLC ₹ 7,943.25
AH85203
873305-35-2 | Aim-100
A2B Chem ₹ 1,157.00 - ₹ 14,774.00

Related Products

Img

MilliporeSigma™

23-980-65MG

--

Img

MilliporeSigma™

23-980-750UG

--

Img

MilliporeSigma™

21-967-45MG

--

Img

MilliporeSigma™

20-048-810MG

--

Img

MilliporeSigma™

21-772-12MG

--

Img

MilliporeSigma™

32-489-75MG

--

Img

MilliporeSigma™

22-049-15MG

--

Img

MilliporeSigma™

20-339-21MG

--

Description

  • A cell-permeable furopyrimidine that acts as a potent, ATP-binding site-targeting, Ack1-selective inhibitor (IC 50 = 22nM) and effectively prevents receptor-mediated Ack1 activation (by >90% in MEF & LAPC4 cultures; 16 h 800nM), while exhibiting much reduced potency against Lyn, Lck, Abl1 and BTK (IC 50 ≥346.7nM) and no inhibitory activity toward 25 other kinases
  • Shown to completely inhibit EGF-induced, but not androgen DHT- (dihydrotestosterone) stimulated, AR transcription activity in serum- and androgen-deprived prostate cancer LAPC4 cutlures
  • Effectively inhibits androgen-independent LNCaP prostate cancer growth both in vitro (by 60%; 72 h 8μM) and in castrated mice in vivo (4mg/kg/96 h injections on day 7/11/15/19/23/27 post tumor transplant).